Vitamin D Activities for Health Outcomes
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Reports describing significant health risks due to inadequate vitamin D status continue to generate considerable interest amongst the medical and lay communities alike. Recent research on the various molecular activities of the vitamin D system, including the nuclear vitamin D receptor and other receptors for 1,25-dihydroxyvitamin D and vitamin D metab- olism, provides evidence that the vitamin D system carries out biological activities across a wide range of tissues similar to other nuclear receptor hormones. This knowledge provides physiological plausibility of the various health benefits claimed to be provided by vitamin D and supports the proposals for conducting clinical trials. The vitamin D system plays criti- cal roles in the maintenance of plasma calcium and phosphate and bone mineral homeo- stasis. Recent evidence confirms that plasma calcium homeostasis is the critical factor modulating vitamin D activity. Vitamin D activities in the skeleton include stimulation or in- hibition of bone resorption and inhibition or stimulation of bone formation. The three major bone cell types, which are osteoblasts, osteocytes and osteoclasts, can all respond to vita- min D via the classical nuclear vitamin D receptor and metabolize 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D to activate the vitamin D receptor and modulate gene expression. Dietary calcium intake interacts with vitamin D metabolism at both the renal and bone tis- sue levels to direct either a catabolic action on the bone through the endocrine system when calcium intake is inadequate or an anabolic action through a bone autocrine or paracrine system when calcium intake is sufficient.
Abstract
Reports describing significant health risks due to inadequate vitamin D status continue to generate considerable interest amongst the medical and lay communities alike. Recent research on the various molecular activities of the vitamin D system, including the nuclear vitamin D receptor and other receptors for 1,25-dihydroxyvitamin D and vitamin D metab- olism, provides evidence that the vitamin D system carries out biological activities across a wide range of tissues similar to other nuclear receptor hormones. This knowledge provides physiological plausibility of the various health benefits claimed to be provided by vitamin D and supports the proposals for conducting clinical trials. The vitamin D system plays criti- cal roles in the maintenance of plasma calcium and phosphate and bone mineral homeo- stasis. Recent evidence confirms that plasma calcium homeostasis is the critical factor modulating vitamin D activity. Vitamin D activities in the skeleton include stimulation or in- hibition of bone resorption and inhibition or stimulation of bone formation. The three major bone cell types, which are osteoblasts, osteocytes and osteoclasts, can all respond to vita- min D via the classical nuclear vitamin D receptor and metabolize 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D to activate the vitamin D receptor and modulate gene expression. Dietary calcium intake interacts with vitamin D metabolism at both the renal and bone tis- sue levels to direct either a catabolic action on the bone through the endocrine system when calcium intake is inadequate or an anabolic action through a bone autocrine or paracrine system when calcium intake is sufficient.
참고문헌 (48)
- "National Health and Medical Research Council (NHMRC), NHMRC additional Levels of Evidence and Grades for Recommendations for Developers of guidelines"[URL]
- Holick MF, "McCollum Award Lecture, 1994: vitamin D--new horizons for the 21st century", Am J Clin Nutr, 60, pp.619~630 (1994)
- Bischoff-Ferrari HA, "A pooled analysis of vitamin D dose requirements for fracture prevention", N Engl J Med, 367, pp.40~49 (2012)
- Ringe JD., "The effect of vitamin D on falls and fractures", Scand J Clin Lab Invest Suppl, 243, pp.73~78 (2012)
- Rush L, "Vitamin D and subsequent all-age and premature mortality: a systematic review", BMC Public Health, 13, pp.679~ (2013)
- Spedding S, "Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases?", Nutrients, 5, pp.5127~5139 (2013)
- Morris HA, "Vitamin D 2013: Where do the hyperbole end and the facts begin?", Nutr Diet, 70, pp.5~6 (2013)
- Morris HA, "Autocrine and paracrine actions of vitamin D", Clin Biochem Rev, 31, pp.129~138 (2010)
- Ryan JW, "Vitamin D activities and metabolic bone disease", Clin Chim Acta, 425, pp.148~152 (2013)
- Haussler MR, "The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful aging", J Steroid Biochem Mol Biol, 121, pp.88~97 (2010)
- Khanal RC, "Membrane receptors for vitamin D metabolites", Crit Rev Eukaryot Gene Expr, 17, pp.31~47 (2007)
- Anderson PH, "Vitamin D actions to regulate calcium and skeletal homeostasis", Clin Biochem, 45, pp.880~886 (2012)
- Anderson PH, "Morris HA. Vitamin D metabolism within bone cells: effects on bone structure and strength", Mol Cell Endocrinol, 347, pp.42~47 (2011)
- Anderson PH, "Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels", Bone, 36, pp.654~662 (2005)
- Hendrix I, "Regulation of gene expression by the CYP27B1 promoter–study of a transgenic mouse model", J Steroid Biochem Mol Biol, 89(90), pp.139~142 (2004)
- Bikle DD, "Vitamin D and skin: Physiology and pathophysiology", Rev Endocr Metab Disord, 13, pp.3~19 (2012)
- Atkins GJ, "Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3", Bone, 40, pp.1517~1528 (2007)
- Yang D, "Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures", J Steroid Biochem Mol Biol, 136, pp.166~170 (2013)
- Anderson PH, "Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model", J Bone Miner Res, 23, pp.1789~1797 (2008)
- Brozek W, "Relative expression of vitamin D hydroxylases, CYP27B1 and CYP24A1, and of cyclooxygenase-2 and heterogeneity of human colorectal cancer in relation to age, gender, tumor location, and malignancy: results from factor and cluster analysis", Cancers (Basel), 4, pp.763~776 (2012)
- Krishnan AV, "Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention", J Steroid Biochem Mol Biol, 136, pp.289~295 (2013)
- Bookout AL, "Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network", Cell, 126, pp.789~799 (2006)
- Haussler MR, "Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention", Nutr Rev, 66(10), pp.98~112 (2008)
- Engel KB, "The glucocorticoid receptor and the coregulator Brm selectively modulate each other’s occupancy and activity in a gene-specific manner", Mol Cell Biol, 31, pp.3267~3276 (2011)
- Dwivedi PP, "Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1", ERK2 and ERK5, 2002, pp.277, 29643~29653
- Boland RL, "VDR activation of intracellular signaling pathways in skeletal muscle", Mol Cell Endocrinol, 347, pp.11~16 (2011)
- Nemere I, "Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells", Proc Natl Acad Sci USA, 101, pp.7392~7397 (2004)
- Bravo S, "The classic receptor for 1alpha,25-dihydroxy vitamin D3 is required for non-genomic actions of 1alpha,25-dihydroxy vitamin D3 in osteosarcoma cells", J Cell Biochem, 99, pp.995~1000 (2006)
- Mulholland DJ, "Interaction of nuclear receptors with the Wnt", beta-catenin, Endocr Rev, pp.2005, 26[DOI]
- Rawadi G, "Wnt signalling pathway: a new target for the treatment of osteoporosis", Expert Opin Ther Targets, 9, pp.1063~1077 (2005)
- Rosen JF, "Rickets with alopecia: an inborn error of vitamin D metabolism", J Pediatr, 94, pp.729~735 (1979)
- Liberman UA, "End-organ resistance to 1,25-dihydroxycholecalciferol", Lancet, 1, pp.504~506 (1980)
- Brooks MH, "Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D", N Engl J Med, 298, pp.996~999 (1978)
- Li YC, "Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia", Proc Natl Acad Sci USA, 94, pp.9831~9835 (1997)
- Amling M, "Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histmorphometric and biomechanical analyses", Endocrinology, 140, pp.4982~4987 (1999)
- Lieben L, "Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization", J Clin Invest, 122, pp.1803~1815 (2012)
- Xue Y, "Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice", Gastroenterology, 136, pp.1317~1327 (2009)
- Erben RG, "Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D", Mol Endocrinol, 16, pp.1524~1537 (2002)
- Cochran M, "The effect of calcitriol on fasting urine calcium loss and renal tubular reabsorption of calcium in patients with mild renal failure--actions of a permissive hormone", Clin Nephrol, 64, pp.98~102 (2005)
- Panda DK, "Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis", J Biol Chem, 279, pp.16754~16766 (2004)
- Yamamoto Y, "Vitamin D receptor in osteoblasts is a negative regulator of bone mass control", Endocrinology, 154, pp.1008~1020 (2013)
- Lieben L, "Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization", J Clin Invest, 122, pp.1803~1815 (2012)
- Gardiner EM, "Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage", FASEB J, 14, pp.1908~1916 (2000)
- Misof BM, "Targeted overexpression of vitamin D receptor in osteoblasts increases calcium concentration without affecting structural properties of bone mineral crystals", Calcif Tissue Int, 73, pp.251~257 (2003)
- Anderson PH, "Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model", J Bone Miner Res, 23, pp.1789~1797 (2008)
- Lee AM, "Adequate dietary vitamin D and calcium are both required to reduce bone turnover and increased bone mineral volume", J Steroid Biochem Mol Bio (2013)[DOI]
- St-Arnaud R, "Vitamin D metabolism, cartilage and bone fracture repair", Mol Cell Endocrinol, 347, pp.48~54 (2011)
- Autier P, "Vitamin D status and ill health: a systematic review", Lancet Diabetes Endocrinol, 2, pp.76~89 (2014)